Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07308977 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Practice of Assisted Vaginal Birth in Egypt

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 5 months later Aug 15, 2026 → Jan 15, 2027
See other at-risk trials from Ain Shams Maternity Hospital

Record History

  1. Primary and study completion pushed from Aug 15, 2026 to Jan 15, 2027v4
  2. Primary and study completion pushed from Jul 15, 2026 to Aug 15, 2026v3
  3. Recruitment opened
    • Primary and study completion pushed from May 15, 2026 to Jul 15, 2026
    • Study sites: 0 to 1
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
In Egypt, the proportion of CSs has been steadily increasing in recent years and has reached an alarming level. According to data from the Royal College of Obstetricians and Gynaecologists (RCOG), approximately 6% of caesarean sections (CS) are performed on average because of inadequate supervision from junior staff members or a lack of training, particularly during the critical decision-making phase of this second stage. The unfamiliarity and lack of experience with operative vaginal delivery is a major cause for the rise in the rate of second stage caesarean section. This survey targets obstetricians with different levels of experience to find practical solutions to increase the rate of assisted vaginal delivery which subsequently will decrease the rate of second stage CS.
Trial Details
NCT Number NCT07308977
Lead Sponsor Ain Shams Maternity Hospital
Conditions
(from sponsor)		 Vaginal Delivery
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov